Renin Inhibition and the Long-Term Renal Function in Patients With Hypertensive Emergency: A Retrospective Cohort Study

Revisiting malignant hypertension: rationale and design of the ‘HAMA cohort’, on behalf of the ESH working group ‘hypertension and the kidney’

(2023) Romain Boulestreau et al.   JOURNAL OF HYPERTENSION

Impact of early initiation of renin-angiotensin blockade on renal function and clinical outcomes in patients with hypertensive emergency: a retrospective cohort study

(2023) Keita Endo et al.   BMC Nephrology

Thirty-Day Readmission Rate Among Patients With Hypertensive Crisis: A Nationwide Analysis

(2022) Muddasir Ashraf et al.   AMERICAN JOURNAL OF HYPERTENSION

The pharmacological management of malignant hypertension

(2020) Philippe Gosse et al.   JOURNAL OF HYPERTENSION

Low Nitric Oxide Bioavailability Increases Renin Production in the Collecting Duct

(2020) Andrew C. Curnow et al.   Frontiers in Physiology

Acute Severe Hypertension

(2019) Aldo J. Peixoto   NEW ENGLAND JOURNAL OF MEDICINE

Thirty-Day Readmissions After Hospitalization for Hypertensive Emergency

(2018) Nilay Kumar et al.   HYPERTENSION

Rehospitalization Rates in Hypertensive Emergency

(2018) Rajiv Agarwal   HYPERTENSION

Calibration and evaluation of routine methods by serum certified reference material for aldosterone measurement in blood

(2016) Tetsuo Nishikawa et al.   ENDOCRINE JOURNAL

Feasibility of fluorescence energy transfer system for imaging the renoprotective effects of aliskiren in diabetic mice

(2016) Kengo Kidokoro et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Mortality and Cardiovascular Risk in Patients With a History of Malignant Hypertension: A Case-Control Study

(2013) Fouad Amraoui et al.   Journal of Clinical Hypertension

Angiotensin II receptor blockade reduces salt sensitivity of blood pressure through restoration of renal nitric oxide synthesis in patients with diabetic nephropathy

(2012) Masahito Imanishi et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

(2012) Hans-Henrik Parving et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study

(2012) Fouad Amraoui et al.   BMC Nephrology

Aliskiren prevents hypertension and reduces asymmetric dimethylarginine in young spontaneously hypertensive rats

(2011) You-Lin Tain et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES